[go: up one dir, main page]

DE50104625D1 - Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung - Google Patents

Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung

Info

Publication number
DE50104625D1
DE50104625D1 DE50104625T DE50104625T DE50104625D1 DE 50104625 D1 DE50104625 D1 DE 50104625D1 DE 50104625 T DE50104625 T DE 50104625T DE 50104625 T DE50104625 T DE 50104625T DE 50104625 D1 DE50104625 D1 DE 50104625D1
Authority
DE
Germany
Prior art keywords
inhibitors
medicine
selective pde
improve perception
perception
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE50104625T
Other languages
English (en)
Inventor
Frank-Gerhard Boess
Martin Hendrix
Gerhard Koenig
Ulrich Niewoehner
Karl-Heinz Schlemmer
Rudy Schreiber
Der Staay Franz-Josef Van
Dagmar Schauss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to DE50104625T priority Critical patent/DE50104625D1/de
Priority claimed from PCT/EP2001/008609 external-priority patent/WO2002009713A2/de
Application granted granted Critical
Publication of DE50104625D1 publication Critical patent/DE50104625D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE50104625T 2000-08-01 2001-07-19 Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung Expired - Fee Related DE50104625D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50104625T DE50104625D1 (de) 2000-08-01 2001-07-19 Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10037411 2000-08-01
DE10122893A DE10122893A1 (de) 2000-08-01 2001-05-11 Selektive PDE 2-Inhibitoren als Arzneimittel zur Verbesserung der Wahrnehmung
PCT/EP2001/008609 WO2002009713A2 (de) 2000-08-01 2001-07-19 Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
DE50104625T DE50104625D1 (de) 2000-08-01 2001-07-19 Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung

Publications (1)

Publication Number Publication Date
DE50104625D1 true DE50104625D1 (de) 2004-12-30

Family

ID=7650927

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10122893A Withdrawn DE10122893A1 (de) 2000-08-01 2001-05-11 Selektive PDE 2-Inhibitoren als Arzneimittel zur Verbesserung der Wahrnehmung
DE50104625T Expired - Fee Related DE50104625D1 (de) 2000-08-01 2001-07-19 Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10122893A Withdrawn DE10122893A1 (de) 2000-08-01 2001-05-11 Selektive PDE 2-Inhibitoren als Arzneimittel zur Verbesserung der Wahrnehmung

Country Status (1)

Country Link
DE (2) DE10122893A1 (de)

Also Published As

Publication number Publication date
DE10122893A1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
PT1307457E (pt) Compostos heterociclicos sua preparacao e utilizacao como medicamentos noemadamente como antibacterianos
ATE540013T1 (de) Naphthalinderivate
AR028567A1 (es) Nuevos derivados de fenil-propargileter
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
CY2013011I2 (el) Μεθοδος χορηγησης διφωσφονικων
SI1686119T1 (sl) Derivati pirimidin-5-ona kot inhibitorji ldl-pla2
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
PT1253932E (pt) Composicoes farmaceuticas de toxina botulinica
NO20032909D0 (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
EE200200604A (et) Dipeptidüüli peptidaasi IV inhibiitorid
ITTO20010008A0 (it) Formulazione farmaceutica
AR027967A1 (es) Derivados de esteres de pirazol como agentes antinflamatorios/analgesicos
AR028596A1 (es) Nuevos derivados de fenilglicina
DE60118469D1 (de) Keramisches tragwerk
IS6798A (is) Atorvastatínhálfkalsíum form VII
EE05020B1 (et) Glburiidi ravimkoostis
DE50107316D1 (de) Neue substituierte imidazotriazinone als pde ii-inhibitoren
IS6575A (is) Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
IS6574A (is) Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
IS6563A (is) Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka
PT1246793E (pt) Derivados substituidos de aminometilfenilciclo-hexano
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
GB0026578D0 (en) Heterocyclic derivatives useful as pharmaceutical agents
AU7847901A (en) Pyrrolidine derivatives as metalloprotease inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee